IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,000 | +25.0% | 506 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $8,000 | -20.0% | 506 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $10,000 | +25.0% | 506 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $8,000 | +33.3% | 506 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $6,000 | -14.3% | 506 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $7,000 | -36.4% | 506 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $11,000 | -21.4% | 506 | 0.0% | 0.01% | -25.0% |
| Q2 2016 | $14,000 | -12.5% | 506 | 0.0% | 0.02% | +6.7% |
| Q1 2016 | $16,000 | -23.8% | 506 | 0.0% | 0.02% | -11.8% |
| Q4 2015 | $21,000 | +23.5% | 506 | 0.0% | 0.02% | -19.0% |
| Q3 2015 | $17,000 | -26.1% | 506 | 0.0% | 0.02% | -16.0% |
| Q2 2015 | $23,000 | -4.2% | 506 | 0.0% | 0.02% | +4.2% |
| Q1 2015 | $24,000 | +50.0% | 506 | 0.0% | 0.02% | +41.2% |
| Q4 2014 | $16,000 | – | 506 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |